Literature DB >> 4103679

Halogenated oxyquinoline derivatives and neurological syndromes.

Y Shimada, T Tsuji, A Igata, H Steinitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4103679     DOI: 10.1016/s0140-6736(71)90023-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Quantitative changes of sural nerves in various neurological diseases.

Authors:  H Tohgi; H Tsukagoshi; Y Toyokura
Journal:  Acta Neuropathol       Date:  1977-05-16       Impact factor: 17.088

Review 2.  The geography of neurology.

Authors:  J D Spillane
Journal:  Br Med J       Date:  1972-05-27

3.  Peripheral neuropathy in ageing rats fed clioquinol and a maize diet.

Authors:  E L Jones; C E Searle; W T Smith
Journal:  Acta Neuropathol       Date:  1973-05-16       Impact factor: 17.088

4.  Experimental myelo-optic neuropathy induced by clioquinol.

Authors:  J Tateishi; S Kuroda; A Saito; S Otsuki
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

5.  [Subacute myelo-optic-neuropathy (S.M.O.N.) following treatment with clioquinol (author's transl)].

Authors:  B Mamoli; A Thaler; P Heilig; G Siakos
Journal:  J Neurol       Date:  1975-06-09       Impact factor: 4.849

Review 6.  Pharmacotherapeutic targets in Alzheimer's disease.

Authors:  Yif'at Biran; Colin L Masters; Kevin J Barnham; Ashley I Bush; Paul A Adlard
Journal:  J Cell Mol Med       Date:  2008-11-18       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.